The balance of STING signaling orchestrates immunity in cancer

KRB Lanng, EL Lauridsen, MR Jakobsen - Nature Immunology, 2024 - nature.com
Over the past decade, it has become clear that the stimulator of interferon genes (STING)
pathway is critical for a variety of immune responses. This endoplasmic reticulum-anchored …

Targeting STING in cancer: Challenges and emerging opportunities

K Zhao, J Huang, Y Zhao, S Wang, J Xu… - Biochimica et Biophysica …, 2023 - Elsevier
The cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING) signaling
pathway is a key pathway through which the host regulates immune responses by …

[HTML][HTML] Loss of SYNCRIP unleashes APOBEC-driven mutagenesis, tumor heterogeneity, and AR-targeted therapy resistance in prostate cancer

X Li, Y Wang, S Deng, G Zhu, C Wang, NA Johnson… - Cancer cell, 2023 - cell.com
Tumor mutational burden and heterogeneity has been suggested to fuel resistance to many
targeted therapies. The cytosine deaminase APOBEC proteins have been implicated in the …

Tissue memory relies on stem cell priming in distal undamaged areas

C Levra Levron, M Watanabe, V Proserpio… - Nature Cell …, 2023 - nature.com
Epithelial cells that participated in wound repair elicit a more efficient response to future
injuries, which is believed to be locally restricted. Here we show that cell adaptation …

cGAS–STING signalling in cancer: striking a balance with chromosomal instability

B Beernaert, EE Parkes - Biochemical Society Transactions, 2023 - portlandpress.com
Chromosomal instability (CIN) is a hallmark of cancer that drives tumour evolution. It is now
recognised that CIN in cancer leads to the constitutive production of misplaced DNA in the …

Uveal melanoma metastasis

E Rossi, M Croce, F Reggiani, G Schinzari, M Ambrosio… - Cancers, 2021 - mdpi.com
Simple Summary Survival after diagnosis of metastatic uveal melanoma has not significantly
improved over decades, most patients die within a year from diagnosis. Uveal melanoma is …

Single-cell RNA sequencing in melanoma: what have we learned so far?

SY Lim, H Rizos - EBioMedicine, 2024 - thelancet.com
Over the past decade, there have been remarkable improvements in the treatment and
survival rates of melanoma patients. Treatment resistance remains a persistent challenge …

[HTML][HTML] SIRT7 downregulation promotes breast cancer metastasis via LAP2α-induced chromosomal instability

Q Huo, S Chen, J Zhuang, C Quan… - International Journal of …, 2023 - ncbi.nlm.nih.gov
Chromosomal instability (CIN) plays an important role in the initiation and progression of
carcinomas. However, the regulatory mechanism of metastasis mediated by CIN in breast …

Cerivastatin synergizes with trametinib and enhances its efficacy in the therapy of uveal melanoma

AA Amaro, R Gangemi, L Emionite, P Castagnola… - Cancers, 2023 - mdpi.com
Simple Summary Uveal melanoma is a rare and aggressive disease. Gα-proteins GNAQ
and GNA11 are driver mutations that activate MAP kinase and YAP/TAZ pathways. BAP1 …

Single cell RNA-sequencing in uveal melanoma: Advances in heterogeneity, tumor microenvironment and immunotherapy

S Tang, Y Zhang, S Huang, T Zhu, X Huang - Frontiers in Immunology, 2024 - frontiersin.org
Uveal melanoma (UM) is a highly aggressive and fatal tumor in the eye, and due the special
biology of UM, immunotherapy showed little effect in UM patients. To improve the efficacy of …